METIS PHARMACEUTICALS
METiS Pharmaceuticals is the world's first AI-driven drug formulation company.
METIS PHARMACEUTICALS
Industry:
Artificial Intelligence Biopharma Medical Device Pharmaceutical
Founded:
2020-01-01
Address:
Hangzhou, Zhejiang, China
Country:
China
Website Url:
http://www.metispharmaceuticals.cn
Total Employee:
51+
Status:
Active
Contact:
+86 0571-86015326
Email Addresses:
[email protected]
Total Funding:
236 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Mobile Non Scaleable Content CNZZ Baidu Maps
Similar Organizations
AccutarBio
AccutarBio employs artificial intelligence to revolutionize drug discovery.
Blade Therapeutics
Blade Therapeutics is a discovery stage drug development company.
Corvus Pharmaceuticals
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
Curon Biopharma
Curon Biopharma is a Healthcare company.
Hangzhou Just Biotherapeutics (Just China)
Hangzhou Just Biotherapeutics is a comprehensive high-tech design company.
KSQ Therapeutics
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
StoneWise
StoneWise is committed to establishing the world's leading intelligent drug discovery platform.
Aria Pharmaceuticals
Aria Pharmaceuticals is a artificial intelligence-driven biopharmaceutical company.
Current Employees Featured
Founder
Investors List
PICC Capital Investment Management
PICC Capital Investment Management investment in Series B - METiS Pharmaceuticals
5Y Capital
5Y Capital investment in Series B - METiS Pharmaceuticals
China Life Investment Holding
China Life Investment Holding investment in Series B - METiS Pharmaceuticals
Lightspeed China Partners
Lightspeed China Partners investment in Series B - METiS Pharmaceuticals
CMB International Capital Corporation
CMB International Capital Corporation investment in Series B - METiS Pharmaceuticals
Sequoia Capital China
Sequoia Capital China investment in Series B - METiS Pharmaceuticals
FREES FUND
FREES FUND investment in Series B - METiS Pharmaceuticals
Monolith Management
Monolith Management investment in Series B - METiS Pharmaceuticals
Sequoia Capital China
Sequoia Capital China investment in Series A - METiS Pharmaceuticals
CMBI Zhaoxin Wuji Fund
CMBI Zhaoxin Wuji Fund investment in Series A - METiS Pharmaceuticals
Official Site Inspections
http://www.metispharmaceuticals.cn
- Host name: 47.96.124.162
- IP address: 47.96.124.162
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
